Department of Anesthesia and Critical Care-Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy;
Department of Anesthesia and Critical Care-Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
Anticancer Res. 2024 Mar;44(3):895-900. doi: 10.21873/anticanres.16883.
Pain is a debilitating phenomenon that dramatically impairs the quality of life of patients. Many chronic conditions, including cancer, are associated with chronic pain. Despite pharmacological efforts that have been conducted, many patients suffering from cancer pain remain without treatment. To date, opioids are considered the preferred therapeutic choice for cancer-related pain management. Unfortunately, opioid treatment causes side effects and inefficiently relieves patients from pain, therefore alternative therapies have been considered, including Cannabis Sativa and cannabinoids. Accumulating evidence has highlighted that an increasing number of patients are choosing to use cannabis and cannabinoids for the management of their soothing and non-palliative cancer pain and other cancer-related symptoms. However, their clinical application must be supported by convincing and reproducible clinical trials. In this review, we provide an update on cannabinoid use for cancer pain management. Moreover, we tried to turn a light on the potential use of cannabis as a possible therapeutic option for cancer-related pain relief.
疼痛是一种使人虚弱的现象,极大地降低了患者的生活质量。许多慢性疾病,包括癌症,都与慢性疼痛有关。尽管已经进行了药物治疗,但许多癌症疼痛患者仍未得到治疗。迄今为止,阿片类药物被认为是治疗癌症相关疼痛的首选治疗方法。不幸的是,阿片类药物治疗会引起副作用,并且不能有效地缓解患者的疼痛,因此已经考虑了替代疗法,包括大麻和大麻素。越来越多的证据表明,越来越多的患者选择使用大麻和大麻素来缓解舒缓和非姑息性癌症疼痛以及其他与癌症相关的症状。然而,其临床应用必须得到令人信服且可重复的临床试验的支持。在这篇综述中,我们提供了大麻素用于癌症疼痛管理的最新信息。此外,我们还试图探讨大麻作为缓解癌症相关疼痛的一种潜在治疗选择的可能性。